{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:27:57Z","timestamp":1789082877639,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KR 3706\/3-1"],"award-info":[{"award-number":["KR 3706\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Asklepios Kliniken Hamburg GmbH Forschungsf\u00f6rderung"},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Previous studies have indicated that glabellar botulinum toxin (BTX) injections may lead to a sustained alleviation of depression. This may be accomplished by the disruption of a facial feedback loop, which potentially mitigates the experience of negative emotions. Accordingly, glabellar BTX injection can attenuate amygdala activity in response to emotional stimuli. A prototypic condition with an excess of negative emotionality and impulsivity accompanied by elevated amygdala reactivity to emotional stimuli is borderline personality disorder (BPD). In order to improve the understanding of how glabellar BTX may affect the processing of emotional stimuli and impulsivity, we conducted a functional magnetic resonance imaging (fMRI) study. Our hypotheses were (1) glabellar BTX leads to increased activation in prefrontal areas during inhibition performance and (2) BTX decreases amygdala activity during the processing of emotional stimuli in general. Using an emotional go-\/no-go paradigm during fMRI, the interference of emotion processing and impulsivity in a sample of n\u2009=\u200945 women with BPD was assessed. Subjects were randomly assigned to BTX treatment or serial acupuncture (ACU) of the head. After 4\u00a0weeks, both treatments led to a reduction in the symptoms of BPD. However, BTX treatment was specifically associated with improved inhibition performance and increased activity in the motor cortex. In addition, the processing of negative emotional faces was accompanied by a reduction in right amygdala activity. This study provides the first evidence that glabellar BTX injections may modify central neurobiological and behavioural aspects of BPD. Since the control treatment produced similar clinical effects, these neurobiological findings may be specific to BTX and not a general correlate of symptomatic improvement.<\/jats:p>","DOI":"10.1038\/s41598-022-17509-0","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T10:02:44Z","timestamp":1660989764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder"],"prefix":"10.1038","volume":"12","author":[{"given":"Tillmann H. C.","family":"Kruger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jara","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Bechinie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insa","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannis","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Kneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai G.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Karst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Fournier-Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"J\u00fcrgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welf","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Dulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wohlmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"He\u00dfelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Axel","family":"Wollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"key":"17509_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/YIC.0000000000000290","volume":"35","author":"MF Brin","year":"2020","unstructured":"Brin, M. F. et al. OnabotulinumtoxinA for the treatment of major depressive disorder: A phase 2 randomized, double-blind, placebo-controlled trial in adult females. Int. Clin. Psychopharmacol. 35, 19\u201328 (2020).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"17509_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","volume":"52","author":"E Finzi","year":"2014","unstructured":"Finzi, E. & Rosenthal, N. E. Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial. J. Psychiatr. Res. 52, 1\u20136 (2014).","journal-title":"J. Psychiatr. Res."},{"key":"17509_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4088\/JCP.13m08845","volume":"75","author":"M Magid","year":"2014","unstructured":"Magid, M. et al. Treatment of major depressive disorder using botulinum toxin A: A 24-week randomized, double-blind, placebo-controlled study. J. Clin. Psychiatry 75, 837\u2013844 (2014).","journal-title":"J. Clin. Psychiatry"},{"key":"17509_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpsychires.2012.01.027","volume":"46","author":"MA Wollmer","year":"2012","unstructured":"Wollmer, M. A. et al. Facing depression with botulinum toxin: A randomized controlled trial. J. Psychiatr. Res. 46, 574\u2013581 (2012).","journal-title":"J. Psychiatr. Res."},{"key":"17509_CR5","first-page":"982","volume":"46","author":"A Zamanian","year":"2017","unstructured":"Zamanian, A., Ghanbari Jolfaei, A., Mehran, G. & Azizian, Z. Efficacy of botox versus placebo for treatment of patients with major depression. Iran. J. Public Health 46, 982\u2013984 (2017).","journal-title":"Iran. J. Public Health"},{"key":"17509_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jpsychires.2021.01.016","volume":"135","author":"J Schulze","year":"2021","unstructured":"Schulze, J. et al. Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis. J. Psychiatr. Res. 135, 332\u2013340 (2021).","journal-title":"J. Psychiatr. Res."},{"key":"17509_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1037\/a0018690","volume":"10","author":"JI Davis","year":"2010","unstructured":"Davis, J. I., Senghas, A., Brandt, F. & Ochsner, K. N. The effects of BOTOX injections on emotional experience. Emotion 10, 433\u2013440 (2010).","journal-title":"Emotion"},{"key":"17509_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/0956797610374742","volume":"21","author":"DA Havas","year":"2010","unstructured":"Havas, D. A., Glenberg, A. M., Gutowski, K. A., Lucarelli, M. J. & Davidson, R. J. Cosmetic use of botulinum toxin-A affects processing of emotional language. Psychol. Sci. 21, 895\u2013900 (2010).","journal-title":"Psychol. Sci."},{"key":"17509_CR9","doi-asserted-by":"publisher","DOI":"10.1037\/10001-000","volume-title":"The Expression of Emotion in Man and Animals","author":"C Darwin","year":"1872","unstructured":"Darwin, C. The Expression of Emotion in Man and Animals (Murray, 1872)."},{"key":"17509_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1037\/0022-3514.54.5.768","volume":"54","author":"F Strack","year":"1988","unstructured":"Strack, F., Martin, L. L. & Stepper, S. Inhibiting and facilitating conditions of the human smile: A nonobtrusive test of the facial feedback hypothesis. J. Pers. Soc. Psychol. 54, 768\u2013777 (1988).","journal-title":"J. Pers. Soc. Psychol."},{"key":"17509_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev.ps.40.020189.001341","volume":"40","author":"PK Adelmann","year":"1989","unstructured":"Adelmann, P. K. & Zajonc, R. B. Facial efference and the experience of emotion. Annu. Rev. Psychol. 40, 249\u2013280 (1989).","journal-title":"Annu. Rev. Psychol."},{"key":"17509_CR12","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.mehy.2011.08.044","volume":"77","author":"T Al Abdulmohsen","year":"2011","unstructured":"Al Abdulmohsen, T. & Kruger, T. H. C. The contribution of muscular and auditory pathologies to the symptomatology of autism. Med. Hypotheses 77, 1038\u20131047 (2011).","journal-title":"Med. Hypotheses"},{"key":"17509_CR13","doi-asserted-by":"publisher","unstructured":"Coles, N. A. et al. A multi-lab test of the facial feedback hypothesis by the many smiles collaboration. (2019). https:\/\/doi.org\/10.31234\/osf.io\/cvpuw","DOI":"10.31234\/osf.io\/cvpuw"},{"key":"17509_CR14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/1745691616674458","volume":"11","author":"E-J Wagenmakers","year":"2016","unstructured":"Wagenmakers, E.-J. et al. Registered replication report: Strack, Martin, & Stepper (1988). Perspect. Psychol. Sci. 11, 917\u2013928 (2016).","journal-title":"Perspect. Psychol. Sci."},{"key":"17509_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1037\/bul0000194","volume":"145","author":"NA Coles","year":"2019","unstructured":"Coles, N. A., Larsen, J. T. & Lench, H. C. A meta-analysis of the facial feedback literature: Effects of facial feedback on emotional experience are small and variable. Psychol. Bull. 145, 610\u2013651 (2019).","journal-title":"Psychol. Bull."},{"key":"17509_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1257786","volume":"192","author":"G Schwartz","year":"1976","unstructured":"Schwartz, G., Fair, P., Salt, P., Mandel, M. & Klerman, G. Facial muscle patterning to affective imagery in depressed and nondepressed subjects. Science 192, 489\u2013491 (1976).","journal-title":"Science"},{"key":"17509_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cercor\/bhn104","volume":"19","author":"A Hennenlotter","year":"2009","unstructured":"Hennenlotter, A. et al. The link between facial feedback and neural activity within central circuitries of emotion\u2014New insights from botulinum toxin-induced denervation of frown muscles. Cereb. Cortex 19, 537\u2013542 (2009).","journal-title":"Cereb. Cortex"},{"key":"17509_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2045-5380-4-11","volume":"4","author":"M Kim","year":"2014","unstructured":"Kim, M. et al. Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: Preliminary findings from an A-B-A design. Biol. Mood Anxiety Disord. 4, 11 (2014).","journal-title":"Biol. Mood Anxiety Disord."},{"key":"17509_CR19","doi-asserted-by":"publisher","unstructured":"Bohus, M. B.-S. Lehrbuch der Verhaltenstherapie, Band 2 (eds. Margraf, J. & Schneider, S.) 471\u2013505 (Springer, 2018). https:\/\/doi.org\/10.1007\/978-3-662-54909-4_25.","DOI":"10.1007\/978-3-662-54909-4_25"},{"key":"17509_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000351122","volume":"47","author":"B Matzke","year":"2014","unstructured":"Matzke, B., Herpertz, S. C., Berger, C., Fleischer, M. & Domes, G. Facial reactions during emotion recognition in borderline personality disorder: A facial electromyography study. Psychopathology 47, 101\u2013110 (2014).","journal-title":"Psychopathology"},{"key":"17509_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1521\/pedi.2008.22.2.135","volume":"22","author":"G Domes","year":"2008","unstructured":"Domes, G. et al. Recognition of facial affect in borderline personality disorder. J. Pers. Disord. 22, 135\u2013147 (2008).","journal-title":"J. Pers. Disord."},{"key":"17509_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1037\/1528-3542.6.4.647","volume":"6","author":"TR Lynch","year":"2006","unstructured":"Lynch, T. R. et al. Heightened sensitivity to facial expressions of emotion in borderline personality disorder. Emotion 6, 647\u2013655 (2006).","journal-title":"Emotion"},{"key":"17509_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.psychres.2017.06.046","volume":"256","author":"C Sinke","year":"2017","unstructured":"Sinke, C., Wollmer, M. A., Kneer, J., Kahl, K. G. & Kruger, T. H. C. Interaction between behavioral inhibition and emotional processing in borderline personality disorder using a pictorial emotional go\/no-go paradigm. Psychiatry Res. 256, 286\u2013289 (2017).","journal-title":"Psychiatry Res."},{"key":"17509_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neubiorev.2015.01.001","volume":"51","author":"L van Zutphen","year":"2015","unstructured":"van Zutphen, L., Siep, N., Jacob, G. A., Goebel, R. & Arntz, A. Emotional sensitivity, emotion regulation and impulsivity in borderline personality disorder: A critical review of fMRI studies. Neurosci. Biobehav. Rev. 51, 64\u201376 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"17509_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000304174","volume":"43","author":"GA Jacob","year":"2010","unstructured":"Jacob, G. A. et al. Impulsivity in borderline personality disorder: Impairment in self-report measures, but not behavioral inhibition. Psychopathology 43, 180\u2013188 (2010).","journal-title":"Psychopathology"},{"key":"17509_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0006-3223(03)00636-X","volume":"54","author":"NH Donegan","year":"2003","unstructured":"Donegan, N. H. et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol. Psychiat. 54, 1284\u20131293 (2003).","journal-title":"Biol. Psychiat."},{"key":"17509_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pscychresns.2008.07.010","volume":"172","author":"HW Koenigsberg","year":"2009","unstructured":"Koenigsberg, H. W. et al. Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res 172, 192\u2013199 (2009).","journal-title":"Psychiatry Res"},{"key":"17509_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.biopsych.2010.10.025","volume":"69","author":"L Schulze","year":"2011","unstructured":"Schulze, L. et al. Neuronal correlates of cognitive reappraisal in borderline patients with affective instability. Biol. Psychiatry 69, 564\u2013573 (2011).","journal-title":"Biol. Psychiatry"},{"key":"17509_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1176\/appi.ajp.2016.16020174","volume":"173","author":"THC Kruger","year":"2016","unstructured":"Kruger, T. H. C., Magid, M. & Wollmer, M. A. Can botulinum toxin help patients with borderline personality disorder?. Am. J. Psychiatry 173, 940\u2013941 (2016).","journal-title":"Am. J. Psychiatry"},{"key":"17509_CR30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1176\/appi.ajp.2018.17091006","volume":"175","author":"MJ Crawford","year":"2018","unstructured":"Crawford, M. J. et al. The clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder: A randomized placebo-controlled trial. AJP 175, 756\u2013764 (2018).","journal-title":"AJP"},{"key":"17509_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2202-9-102","volume":"9","author":"D Swick","year":"2008","unstructured":"Swick, D., Ashley, V. & Turken, A. U. Left inferior frontal gyrus is critical for response inhibition. BMC Neurosci. 9, 102 (2008).","journal-title":"BMC Neurosci."},{"key":"17509_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.neuron.2016.12.013","volume":"93","author":"JR Wessel","year":"2017","unstructured":"Wessel, J. R. & Aron, A. R. On the globality of motor suppression: Unexpected events and their influence on behavior and cognition. Neuron 93, 259\u2013280 (2017).","journal-title":"Neuron"},{"key":"17509_CR33","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.neubiorev.2008.08.013","volume":"33","author":"CM Stinear","year":"2009","unstructured":"Stinear, C. M., Coxon, J. P. & Byblow, W. D. Primary motor cortex and movement prevention: Where Stop meets Go. Neurosci. Biobehav. Rev. 33, 662\u2013673 (2009).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"17509_CR34","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/brain\/awh473","volume":"128","author":"M Orth","year":"2005","unstructured":"Orth, M., Amann, B., Robertson, M. M. & Rothwell, J. C. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain 128, 1292\u20131300 (2005).","journal-title":"Brain"},{"key":"17509_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neulet.2007.04.024","volume":"419","author":"MM Richter","year":"2007","unstructured":"Richter, M. M., Ehlis, A.-C., Jacob, C. P. & Fallgatter, A. J. Cortical excitability in adult patients with attention-deficit\/hyperactivity disorder (ADHD). Neurosci. Lett. 419, 137\u2013141 (2007).","journal-title":"Neurosci. Lett."},{"key":"17509_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/npp.2009.121","volume":"35","author":"CA Hartley","year":"2010","unstructured":"Hartley, C. A. & Phelps, E. A. Changing fear: The neurocircuitry of emotion regulation. Neuropsychopharmacology 35, 136\u2013146 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"17509_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/brain.2010.0001","volume":"1","author":"KR Cullen","year":"2011","unstructured":"Cullen, K. R. et al. Amygdala functional connectivity in young women with borderline personality disorder. Brain Connect. 1, 61\u201371 (2011).","journal-title":"Brain Connect."},{"key":"17509_CR38","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1017\/S0033291714000324","volume":"44","author":"A Krause-Utz","year":"2014","unstructured":"Krause-Utz, A. et al. Amygdala and anterior cingulate resting-state functional connectivity in borderline personality disorder patients with a history of interpersonal trauma. Psychol. Med. 44, 2889\u20132901 (2014).","journal-title":"Psychol. Med."},{"key":"17509_CR39","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/scan\/nsw016","volume":"11","author":"C Paret","year":"2016","unstructured":"Paret, C. et al. Alterations of amygdala-prefrontal connectivity with real-time fMRI neurofeedback in BPD patients. Soc. Cogn. Affect. Neurosci. 11, 952\u2013960 (2016).","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"17509_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pscychresns.2007.03.006","volume":"155","author":"MJ Minzenberg","year":"2007","unstructured":"Minzenberg, M. J., Fan, J., New, A. S., Tang, C. Y. & Siever, L. J. Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: An event-related fMRI study. Psychiatry Res. Neuroimaging 155, 231\u2013243 (2007).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"17509_CR41","first-page":"418","volume":"34","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli, P. et al. Functional atlas of emotional faces processing: A voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J. Psychiatry Neurosci. 34, 418\u2013432 (2009).","journal-title":"J. Psychiatry Neurosci."},{"key":"17509_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.psc.2018.07.009","volume":"41","author":"R Shah","year":"2018","unstructured":"Shah, R. & Zanarini, M. C. Comorbidity of borderline personality disorder. Psychiatr. Clin. N. Am. 41, 583\u2013593 (2018).","journal-title":"Psychiatr. Clin. N. Am."},{"key":"17509_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/02698811211069108","volume":"36","author":"MA Wollmer","year":"2022","unstructured":"Wollmer, M. A. et al. Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial. J. Psychopharmacol. 36, 159\u2013169 (2022).","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"17509_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/jcm8081140","volume":"8","author":"M Armour","year":"2019","unstructured":"Armour, M.et al.. Acupuncture for depression: a systematic review and meta-analysis. J. Clin. Med. 8(8), 1140. https:\/\/doi.org\/10.3390\/jcm8081140 (2019).","journal-title":"J. Clin. Med."},{"issue":"6","key":"17509_CR45","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/NMD.0b013e31803044f8","volume":"195","author":"M Hollifield","year":"2007","unstructured":"Hollifield, M., Sinclair-Lian, N., Warner, T.D & Hammerschlag, R. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis 195(6), 504\u2013513. https:\/\/doi.org\/10.1097\/NMD.0b013e31803044f8 (2007).","journal-title":"J Nerv Ment Dis"},{"issue":"1-2","key":"17509_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/aim.25.1-2.1","volume":"25","author":"K Pilkington","year":"2007","unstructured":"Pilkington, K.,\nKirkwood, G., Rampes, H., Cummings, M & Richardson. J. Acupuncture for Anxiety and Anxiety Disorders: A Systematic Literature Review. Acupuncture in Medicine 25(1\u20132), 1\u201310. https:\/\/doi.org\/10.1136\/aim.25.1-2.1 (2007).","journal-title":"Acupuncture in Medicine"},{"key":"17509_CR47","doi-asserted-by":"publisher","unstructured":"Shen, X., Xia, J. & Adams, C.E. Acupuncture for schizophrenia. Cochrane Database Syst Rev 10. https:\/\/doi.org\/10.1002\/14651858.CD005475.pub2 (2014).","DOI":"10.1002\/14651858.CD005475.pub2"},{"issue":"3","key":"17509_CR48","doi-asserted-by":"publisher","first-page":"CD004046","DOI":"10.1002\/14651858.CD004046.pub4","volume":"3","author":"CA Smith","year":"2007","unstructured":"Smith, C.A., Armour,\nM., Lee, M.S., Wang, L.Q & Hay, P.J Acupuncture for depression. Cochrane Database Syst Rev 3(3), CD004046. https:\/\/doi.org\/10.1002\/14651858.CD004046.pub4 (2018).","journal-title":"Cochrane Database Syst Rev"},{"key":"17509_CR49","unstructured":"Dilling, H., Mombour, W., Schmidt, M. H., Schulte-Markwort, E. & Remschmidt, H. Internationale Klassifikation psychischer St\u00f6rungen\u202f: ICD-10 Kapitel V (F) klinisch-diagnostische Leitlinien. (Hogrefe, 2015)."},{"key":"17509_CR50","unstructured":"Fydrich, T., Renneberg, B., Schmitz, B. & Wittchen, H.-U. SKID II. Strukturiertes Klinisches Interview f\u00fcr DSM-IV, Achse II: Pers\u00f6nlichkeitsst\u00f6rungen. (Hogrefe, 1997)."},{"key":"17509_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/PRA.0000000000000136","volume":"22","author":"AK Parsaik","year":"2016","unstructured":"Parsaik, A. K. et al. Role of botulinum toxin in depression. J. Psychiatr. Pract. 22, 99\u2013110 (2016).","journal-title":"J. Psychiatr. Pract."},{"key":"17509_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1521\/pedi.17.3.233.22147","volume":"17","author":"MC Zanarini","year":"2003","unstructured":"Zanarini, M. C. Zanarini rating scale for borderline personality disorder (ZAN-BPD): A continuous measure of DSM-IV borderline psychopathology. J. Pers. Disord. 17, 233\u2013242 (2003).","journal-title":"J. Pers. Disord."},{"key":"17509_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0028-1104598","volume":"59","author":"M Wolf","year":"2009","unstructured":"Wolf, M. et al. Kurzversion der Borderline-Symptom-Liste (BSL-23): Entwicklung und \u00dcberpr\u00fcfung der psychometrischen Eigenschaften. PPmP Psychotherapie Psychosomatik Medizinische Psychologie 59, 321\u2013324 (2009).","journal-title":"PPmP Psychotherapie Psychosomatik Medizinische Psychologie"},{"key":"17509_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jpsychires.2015.08.006","volume":"69","author":"S Jung","year":"2015","unstructured":"Jung, S., Wollmer, M. A. & Kruger, T. H. C. The Hamburg-Hannover Agitation Scale (H2A): Development and validation of a self-assessment tool for symptoms of agitation. J. Psychiatr. Res. 69, 158\u2013165 (2015).","journal-title":"J. Psychiatr. Res."},{"key":"17509_CR55","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.psychres.2008.05.006","volume":"168","author":"N Tottenham","year":"2009","unstructured":"Tottenham, N. et al. The NimStim set of facial expressions: Judgments from untrained research participants. Psychiatry Res. 168, 242\u2013249 (2009).","journal-title":"Psychiatry Res."},{"key":"17509_CR56","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/hbm.22768","volume":"36","author":"KA Tsvetanov","year":"2015","unstructured":"Tsvetanov, K. A. et al. The effect of ageing on fMRI: Correction for the confounding effects of vascular reactivity evaluated by joint fMRI and MEG in 335 adults: Vascular Influences on BOLD Signal with Ageing. Hum. Brain Mapp. 36, 2248\u20132269 (2015).","journal-title":"Hum. Brain Mapp."},{"key":"17509_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fpsyt.2014.00036","volume":"5","author":"MA Wollmer","year":"2014","unstructured":"Wollmer, M. A. et al. Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial. Front. Psychiatry 5, 36 (2014).","journal-title":"Front. Psychiatry"},{"key":"17509_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer, N. et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273\u2013289 (2002).","journal-title":"Neuroimage"},{"issue":"1","key":"17509_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/scan\/nsm006","volume":"2","author":"RA Poldrack","year":"2007","unstructured":"Poldrack, R. A.  Region of Interest Analysis for FMRI. Soc Cogn Affect Neurosci  2(1), 67\u201370. https:\/\/doi.org\/10.1093\/scan\/nsm006 (2007).","journal-title":"Soc Cogn Affect Neurosci"},{"issue":"1","key":"17509_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/(SICI)1097-0193(1996)4:1","volume":"4","author":"RA Worsley","year":"1996","unstructured":"Worsley, K.\nJ.et al. A Unified Statistical Approach for Determining Significant Signals in Images of Cerebral Activation. Hum. Brain Mapp. 4(1), 58\u201373. https:\/\/doi.org\/10.1002\/(SICI)1097-0193(1996)4:1 (1996).","journal-title":"Hum. Brain Mapp."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17509-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:28:10Z","timestamp":1669361290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17509-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17509"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17509-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kruger has received honoraria for talks and\/or advisory board activities from Allergan, Lilly, Lundbeck, Otsuka, Schwabe, Servier, and Trommsdorf. Authors Kruger and Wollmer were members of an advisory board of Allergan. All other authors have no conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14197"}}